Literature DB >> 29907875

A novel homozygous missense mutation in the SH3-binding motif of STAMBP causing microcephaly-capillary malformation syndrome.

Ikumi Hori1, Fuyuki Miya2,3, Yutaka Negishi1, Ayako Hattori1, Naoki Ando1, Keith A Boroevich3, Nobuhiko Okamoto4, Mitsuhiro Kato5, Tatsuhiko Tsunoda2,3, Mami Yamasaki6, Yonehiro Kanemura7,8, Kenjiro Kosaki9, Shinji Saitoh10.   

Abstract

Microcephaly-capillary malformation syndrome is a congenital and neurodevelopmental disorder caused by biallelic mutations in the STAMBP gene. Here we identify the novel homozygous mutation located in the SH3 binding motif of STAMBP (NM_006463.4) (c.707C>T: p.Ser236Phe) through whole-exome sequencing. The case patient was a 2-year-old boy showing severe global developmental delay, progressive microcephaly, refractory seizures, dysmorphic facial features, and multiple capillary malformations. Immunoblot analysis of patient-derived lymphoblastoid cell lines (LCLs) revealed a severe reduction in STAMBP expression, indicating that Ser236Phe induces protein instability. STAMBP interacts with the SH3 domain of STAM and transduces downstream signals from the Jaks-STAM complex. The substitution of Ser236Phe found in the case patient was located in the SH3-binding motif, and we propose the mutation may block STAM binding and subsequently induce STAMBP degradation. Contrary to previously reported STAMBP mutations, the Ser236Phe mutation did not lead to constitutive activation of the PI3K-AKT-mTOR pathway in patient-derived LCLs, as indicated by the expression of phosphorylated S6 ribosomal protein, suggesting that it is not the major pathomechanism underlying the disorder in this patient.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29907875     DOI: 10.1038/s10038-018-0482-3

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  16 in total

1.  A new syndrome with multiple capillary malformations, intractable seizures, and brain and limb anomalies.

Authors:  Melissa T Carter; Michael T Geraghty; Laura De La Cruz; R Ross Reichard; Luigi Boccuto; Charles E Schwartz; Carol L Clericuzio
Journal:  Am J Med Genet A       Date:  2011-02       Impact factor: 2.802

2.  Multiple capillary skin malformations, epilepsy, microcephaly, mental retardation, hypoplasia of the distal phalanges: report of a new case and further delineation of a new syndrome.

Authors:  Bertrand Isidor; Sébastien Barbarot; Claire Bénéteau; Cédric Le Caignec; Albert David
Journal:  Am J Med Genet A       Date:  2011-05-05       Impact factor: 2.802

3.  The microcephaly-capillary malformation syndrome.

Authors:  Ghayda M Mirzaa; Alex R Paciorkowski; Christopher D Smyser; Marcia C Willing; Anne C Lind; William B Dobyns
Journal:  Am J Med Genet A       Date:  2011-08-03       Impact factor: 2.802

4.  Loss of neurons in the hippocampus and cerebral cortex of AMSH-deficient mice.

Authors:  N Ishii; Y Owada; M Yamada; S Miura; K Murata; H Asao; H Kondo; K Sugamura
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

5.  Possible involvement of a novel STAM-associated molecule "AMSH" in intracellular signal transduction mediated by cytokines.

Authors:  N Tanaka; K Kaneko; H Asao; H Kasai; Y Endo; T Fujita; T Takeshita; K Sugamura
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

6.  Microcephaly-capillary malformation syndrome: Brothers with a homozygous STAMBP mutation, uncovered by exome sequencing.

Authors:  Muhammad Imran Naseer; Sameera Sogaty; Mahmood Rasool; Adeel G Chaudhary; Yousif Ahmed Abutalib; Susan Walker; Christian R Marshall; Daniele Merico; Melissa T Carter; Stephen W Scherer; Mohammad H Al-Qahtani; Mehdi Zarrei
Journal:  Am J Med Genet A       Date:  2016-08-17       Impact factor: 2.802

7.  Predictors of hippocampal, cerebral, and cerebellar volume reduction in childhood epilepsy.

Authors:  J A Lawson; S Vogrin; A F Bleasel; M J Cook; L Burns; L McAnally; J Pereira; A M Bye
Journal:  Epilepsia       Date:  2000-12       Impact factor: 5.864

8.  AMSH interacts with ESCRT-0 to regulate the stability and trafficking of CXCR4.

Authors:  Maria I Sierra; Michelle H Wright; Piers D Nash
Journal:  J Biol Chem       Date:  2010-02-16       Impact factor: 5.157

9.  p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy.

Authors:  Serhiy Pankiv; Terje Høyvarde Clausen; Trond Lamark; Andreas Brech; Jack-Ansgar Bruun; Heidi Outzen; Aud Øvervatn; Geir Bjørkøy; Terje Johansen
Journal:  J Biol Chem       Date:  2007-06-19       Impact factor: 5.157

10.  Mutations in STAMBP, encoding a deubiquitinating enzyme, cause microcephaly-capillary malformation syndrome.

Authors:  Laura M McDonell; Ghayda M Mirzaa; Diana Alcantara; Jeremy Schwartzentruber; Melissa T Carter; Leo J Lee; Carol L Clericuzio; John M Graham; Deborah J Morris-Rosendahl; Tilman Polster; Gyula Acsadi; Sharron Townshend; Simon Williams; Anne Halbert; Bertrand Isidor; Albert David; Christopher D Smyser; Alex R Paciorkowski; Marcia Willing; John Woulfe; Soma Das; Chandree L Beaulieu; Janet Marcadier; Michael T Geraghty; Brendan J Frey; Jacek Majewski; Dennis E Bulman; William B Dobyns; Mark O'Driscoll; Kym M Boycott
Journal:  Nat Genet       Date:  2013-03-31       Impact factor: 38.330

View more
  2 in total

Review 1.  Early‑onset epilepsy and microcephaly‑capillary malformation syndrome caused by a novel STAMBP mutation in a Chinese boy.

Authors:  Fangrui Wu; Ying Dai; Juan Wang; Min Cheng; Yanqin Wang; Xiujuan Li; Ping Yuan; Shuang Liao; Li Jiang; Jin Chen; Lisi Yan; Min Zhong
Journal:  Mol Med Rep       Date:  2019-10-17       Impact factor: 2.952

2.  Novel compound heterozygous mutation in STAMBP causes a neurodevelopmental disorder by disrupting cortical proliferation.

Authors:  Meixin Hu; Huiping Li; Zhuxi Huang; Dongyun Li; Ying Xu; Qiong Xu; Bo Chen; Yi Wang; Jingxin Deng; Ming Zhu; Weijun Feng; Xiu Xu
Journal:  Front Neurosci       Date:  2022-08-10       Impact factor: 5.152

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.